11 results
diagnosis treatment barre guillain infections neurology rheumatology 1 adjuvant agitation amiodarone antibiotics calcium cdi cdiff clostridioides clostridium corticosteroids cppd criticalcare
Adjuvant therapies in critical care: steroids to treat infectious diseases - Severe Community Acquired Pneumonia
respiratory distress syndrome ... jirovecii pneumonia, id ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook Clinical Presentation + Progression:
Perforation) Pathophysiology ... Epidemiology: • #1 ... immunocompromised, IBD ... 10 mg/kg IV x 1 ... #treatment #infectiousdiseases
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Therapy, by Clinical Syndrome ... Soft-tissue only: • Mild ... #antibiotics #pharmacology ... #management
Guillain-Barre Syndrome - Summary Acute AIDP that presents with rapidly progressive flaccid weakness Epidemiology: • 1-2 cases/100,000 per
Epidemiology: • 1- ... Guillain-Barre Pathophysiology ... • Weakness: mild ... main variants: (1) ... #diagnosis #management
Guillain-Barré Syndrome (GBS) Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness Epidemiology: • Incidence: 1
Guillain-Barré Syndrome ... can vary from mild ... the underlying pathophysiology ... Guillain #Barre #Syndrome ... #diagnosis #management
Amiodarone Induced Lung Toxicity Summary Who? • 5% of patients • Dose ≥ 400 mg per day How? Possible
respiratory distress syndrome ... including: 1. ... : Interstitial pneumonitis ... Exclusion of other ILDs ... Pulmonary #diagnosis #management
Pain, Agitation, and Delirium (PAD) in the ICU Addressing the ICU Triad (PAD) can be accomplished through
in critically ill ... Target -1, but will ... Propofol infusion syndrome ... No pharmacologic ... CriticalCare #diagnosis #management
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
Epidemiology: • F > M: 9:1 ... Antinuclear antibodies ≥ 1: ... • Interstitial Pneumonitis ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
Strongyloidiasis Treatment Asymptomatic ± eosinophilia (Very low risk): • Diagnostic: Serology, Stool Ova and parasites (O&P) examination
2 doses on day 1 ... 2 doses on day 1 ... 14-days apart Mild ... hyperinfection syndrome ... strongyloides #parastie #infectiousdiseases
Hemophagocytic Lymphohistiocytosis (HLH) High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
recognition and management ... dysfunction. 1. ... hyperinflammatory syndrome ... patients with the HLH syndrome ... Pathophysiology
No results found for "pneumonitis ild 1: pathophysiology pharmacology management infectiousdiseases idsa syndrome"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #pneumonitis #ild #1: #pathophysiology #pharmacology #management #infectiousdiseases #idsa #syndrome